For successful effector functions, it is imperative for CAR T cells to rapidly recognize tumor cells and facilitate CAR receptor binding with the CAR antigen (e.g., CD19, CD20, CD22, BCMA, etc.)expressed on tumor cells (154). Here, CD19 is linked to neoplasm.